Pharmaceuticals, Biotechnology and Life Sciences
Survival Benefit Now Observed with KEYTRUDA in Combination with Chemotherapy in All Patient Populations (Regardless of PD-L1 Expression) and with…
Survival Benefit Now Observed with KEYTRUDA in Combination with Chemotherapy in All Patient Populations (Regardless of PD-L1 Expression) and with…
Also Presenting Preclinical Data on Two Additional Pipeline Products PHILADELPHIA–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/AML?src=hash" target="_blank"gt;#AMLlt;/agt;–SFA Therapeutics, Inc. will be presenting human Psoriasis…
DUBLIN–(BUSINESS WIRE)–The “Jalyn – API Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Jalyn – API Insight, 2019…
DUBLIN–(BUSINESS WIRE)–The “Jalyn – API Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Jalyn – API Insight, 2019…
DUBLIN–(BUSINESS WIRE)–The “Mucosta – API Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Mucosta – API Insight, 2019…
DUBLIN–(BUSINESS WIRE)–The “Isentress – API Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Isentress – API Insight, 2019…
DUBLIN–(BUSINESS WIRE)–The “Nexium – API Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Nexium – API Insight, 2019…
LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/EAACI2019?src=hash" target="_blank"gt;#EAACI2019lt;/agt;–Stallergenes Greer today announced that house dust mite (HDM) induced allergic rhinitis, its treatment with sublingual tablets…
Beam Therapeutics and Bio Palette today announced an exclusive
cross-license agreement around each companies’ base editing intellectual
property.